Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227
Bristol-Myers Squibb
Julie R Brahmer; Jong-Seok Lee; Tudor-Eliade Ciuleanu; Reyes Bernabe Caro; Makoto Nishio; Laszlo Urban; Clarisse Audigier-Valette; Lorena Lupinacci; Randeep Sangha; Adam Pluzanski; Jacobus Burgers; Mauricio Mahave; Samreen Ahmed; Adam J Schoenfeld; Luis G Paz-Ares; Martin Reck; Hossein Borghaei; Kenneth J O'Byrne; Ravi G Gupta; Judith Bushong; Li Li; Steven I Blum; Laura J Eccles; Suresh S Ramalingam